Infectious Disease and Pathogen Expertise

In the face of a relentless array of infectious diseases and pathogens, preclinical research and testing stands as a critical line of defense. Southern Research is dedicated to providing comprehensive preclinical infectious disease services, empowering researchers to combat these threats and develop medical countermeasures.


Comprehensive Services Spanning the Infectious Disease Spectrum

Your Partner in Preclinical Infectious Disease Research and Testing

Our team of seasoned SMEs (subject matter experts), immunologists, and cellular biologists possesses extensive experience in understanding the pathogenesis, immmunogenicity, and disease intervention strategies for a wide range of infectious diseases. We are proficient in a variety of in vitro and in vivo infectious disease assays, capable of evaluating the efficacy, safety, and pharmacokinetic properties of potential therapeutics.

We offer a comprehensive suite of preclinical infectious disease services—including Select Agent and BSL-3 capabilities—tailored to address the diverse challenges posed by these diseases, encompassing every stage of the research process:

Pathogen Identification, Propagation, and Characterization: We help you identify and characterize novel pathogens, providing crucial insights into their biology and potential therapeutic targets.

Antimicrobial Compound Screening and Optimization: We utilize a range of in vitro screening assays to identify promising antimicrobial candidates and optimize their potency and spectrum of activity.

Efficacy and Safety Testing in Animal Models: We conduct rigorous efficacy and safety testing in animal models to assess therapeutic potential.

Regulatory Support and IND Preparation: We guide you through the intricate regulatory landscape, ensuring compliance with FDA guidelines and facilitating the preparation of Investigational New Drug (IND) applications.

Additionally, we offer assay development, animal model development, clinical trial support, and a repository of potential pandemic pathogens.


Virology is the scientific study of viruses, a group of small, infectious agents that replicate only within living cells. Viruses can infect all types of organisms, from animals and plants to bacteria and archaea. They are responsible for a wide range of diseases, including the common cold, influenza, AIDS, and COVID-19,

Learn more about our preclinical services for virology research and testing here.


Bacteriology is a branch of microbiology that studies bacteria, a group of single-celled organisms that are ubiquitous on Earth. Bacteria are prokaryotes, which means they lack a nucleus and other membrane-bound organelles.

Learn more about our preclinical services for bacteriology research and testing here.

Emerging Pathogens

Emerging pathogens are infectious agents that have recently been discovered or have shown an increase in prevalence in human populations. These pathogens can cause new diseases or exacerbate existing ones, posing a significant threat to global health.

Learn more about our preclinical services for emerging pathogens research and testing here.

Prion Disease

Prion diseases are a class of rare, progressive, neurodegenerative disorders that affect both humans and animals. They are caused by the misfolding of a normal protein called a prion, which leads to the formation of abnormal protein aggregates in the brain and other tissues. These aggregates can damage and kill neurons, leading to a progressive decline in cognitive function and other neurological impairments.

Learn more about our preclinical services for prion disease research and testing here.


The Power of Collaboration

By partnering with Southern Research, you gain access to a wealth of expertise, resources, and infrastructure, enabling you to focus on your core competencies while we handle the complexities of preclinical infectious disease research and testing.

Our Experts

Jennifer Pickens, Ph.D.

Director of Infectious Disease Research

Fusataka Koide, M.S.

Senior Director of Business Development

Rebecca Boohaker, Ph.D.

Director of Oncology

Partner With Us

Southern Research is committed to safeguarding global health by providing world-class preclinical infectious disease research and testing services. Contact us today to discuss your preclinical and clinical infectious disease research and testing needs, and let us help you make a profound impact on the fight against infectious diseases worldwide.

Southern Research News

Southern Research awards biotech funds, bringing new jobs and business to Alabama

June 28, 2024

June 27, 2024, Birmingham, Ala – Southern Research has awarded more than $2.7 million in funds to eight biotech companies through a fund established as a result of the Innovate Alabama Tax Credit.
Read More

Southern Research Selects Chief Operating Officer

May 9, 2024

May 8, 2024 Birmingham, Ala. – Harry C. Ledebur, Jr., Ph.D., is joining Southern Research as Chief Operating Officer, bringing to the role more than 25 years of experience across the pharmaceutical, biotechnology, and contract-research industry. In his new position at Southern ...
Read More

Southern Research Awarded Grant to Develop Novel Antidotes for Arsenical Poisoning

April 11, 2024

Project Aims to Deliver Safer and More Effective Treatments for Cutaneous Injuries Southern Research is pleased to announce the award of a UG3/UH3 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (N...
Read More